Hamilton Thorne Ltd (CVE:HTL) – Zacks Investment Research cut their FY2018 earnings per share estimates for shares of Hamilton Thorne in a report issued on Tuesday. Zacks Investment Research analyst A. Dushyanth now forecasts that the company will post earnings of $0.02 per share for the year, down from their previous forecast of $0.03.
WARNING: “Zacks Investment Research Equities Analysts Reduce Earnings Estimates for Hamilton Thorne Ltd (HTL)” was reported by Week Herald and is the sole property of of Week Herald. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://weekherald.com/2017/09/09/zacks-investment-research-equities-analysts-reduce-earnings-estimates-for-hamilton-thorne-ltd-htl.html.
Hamilton Thorne Company Profile
Hamilton Thorne Ltd. is engaged in the development, manufacture and sale of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets. The Company offers Clinical lasers, Research lasers and Clinical Sperm Analysis Products.
Receive News & Ratings for Hamilton Thorne Ltd Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Hamilton Thorne Ltd and related companies with MarketBeat.com’s FREE daily email newsletter.